India – Talk Bio

Eli Lilly to Invest Over $1 Billion to Expand Manufacturing Footprint in India

2 weeks ago talkbio0Tagged Alzheimer 's, Autoimmune, contract manufacturing, Diabetes, eli lilly, expansion, Hyderabad, India, Malignant Neoplasms, Manufacturing, Obesity

Eli Lilly; India; manufacturing expansion; contract manufacturing; Hyderabad; pharmaceuticals; obesity; diabetes; Alzheimer’s; cancer; autoimmune

Eli Lilly Commits Over $1 Billion to Expand India Manufacturing Footprint

2 weeks ago talkbio0Tagged contract manufacturing, eli lilly, Hyderabad, India, Investments, Manufacturing

Eli Lilly; India; manufacturing; investment; contract manufacturing; pharmaceuticals; Hyderabad

Hikal Receives US FDA Warning Letter Over Metal Contamination at Jigani Facility

2 months ago talkbio0Tagged adulteration, alpha 1-antitrypsin, Cautionary Warning, GMP violations, Hikal, India, Jigani Facility, Letter [Publication Type], Manufacturer, Metals, pharmaceutical manufacturing, Regulatory Compliance, United States Food and Drug Administration

Hikal; FDA warning letter; metal contamination; API manufacturer; GMP violations; Jigani facility; India; pharmaceutical manufacturing; regulatory compliance

AstraZeneca Ends Manufacturing License at Indian Plant and Exits Site as Part of Global Strategy

2 months ago talkbio0Tagged AstraZeneca, Bangalore plant, Contract agreement, Drug Industry, global strategy, India, Manufacturing, manufacturing license, Site of exit

AstraZeneca; India; manufacturing license; site exit; Bangalore plant; contract manufacturing; global strategy; pharmaceutical industry

BioSpace Presents the World Atlas of GLP-1s

7 months ago talkbio0Tagged BioSpace, Brazil, Cervical Atlas, China, Eli Lilly, GLP-1s, Glucagon-Like Peptide 1, India, Nordisk, Wegovy, World

Eli Lilly, Wegovy, India, China, BioSpace, World, Cervical Atlas, GLP-1s, Nordisk, Glucagon-Like Peptide 1, Brazil, India

Amgen expands Indian footprint with $200M tech hub

8 months ago talkbio0Tagged amgen, Artificial Intelligence, Data Science, India, India 's, Site, Technology

Amgen, India, Technology, Site, Data Science, Aortic Valve Insufficiency, India ‘s

Lonza Expands Gelatin Capsule Production in India and China Amid Plans to Exit Capsules Business

10 months ago talkbio0Tagged capsule (pharmacologic), China, Exit Strategy, expansion, gelatin, India, Lonza

Lonza, Capsules & Health Ingredients, Gelatin Capsules, India, China, Expansion, Exit Strategy